title: Macro trends in pharmaceutical innovation.
abstract: Critics decry the lack of 'truly innovative' new medicines and question the role of the pharmaceutical industry in creating the few that are developed. Is this an accurate portrayal of the state of pharmaceutical innovation? Does major pharma still innovate? If so, how? Must the industry innovate to survive? These and related issues are discussed.
authors.affiliation: Crownstone, 3331 Street Road, Suite 140, Bensalem, Pennsylvania 19020, USA. fred@crownstonegroup.com
authors.forename: Fredric J
authors.initials: FJ
authors.lastname: Cohen
mesh_terms: D002986:Clinical Trials as Topic / Q000145:classification; D004345:Drug Industry / Q000191:economics / Q000379:methods / Q000639:trends*; D006801:Humans; D009316:National Institutes of Health (U.S.); D009936:Organizational Innovation; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis / Q000145:classification / Q000191:economics; D018581:Technology Transfer; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004364:Pharmaceutical Preparations